Home

Meet us at

 September 04, 2019
Publication Half Year Report 2019

Telecon 14:00h CET

 September 05, 2019
UBS | Best of Switzerland Conference

Dorint Airport-Hotel | Riethofstrasse 40 | CH-8152 Opfikon-Glattbrugg

 September 06, 2019
KOL Meeting with Dr. Peter Kaufman, Co-Chair of the Balixafortide FORTRESS Trial

Hotel The Benjamin | 125 East 50th Street | 10022 New York | 08:00h to 09:30h EDT | Webcast

 September 09, 2019
Wainwright Investors Conference

The Lotte Palace Hotel | 455 Madison Ave. | 10022 New York | USA

 September 16, 2019
KOL Meeting with Dr. Javier Cortez, Co-Chair of the Balixafortide FORTRESS Trial

Haus Zum Rueden | Limmatquai 42, Zürich | 12:15h to 13:45h CET | Webcast

 September 18, 2019
Investora | Zürich

Samsung Hall | Hoffnigstrasse 1 | CH-8600 Dübendorf | Presentation 15:25h – 16:10h

 

Innovative medicines pipeline

CXCR4 antagonist

Fast Track Designation granted by FDA

Phase III

Antibiotics

Preclinical

Macrocycle discovery platform

New modalities to address challenging biological targets